Dimerix Stock

Dimerix ROCE

The Return on Capital Employed (ROCE) of Dimerix (DXB.AX) as of Sep 3, 2026 is -231.75 %. In the previous year, Return on Capital Employed (ROCE) was -93.05 % — a change of 149.05% (lower).

ROCE

-231.75 %

YoY

149.05%

Last updated:

In 2026, Dimerix's return on capital employed (ROCE) was -231.75 %, a 149.05% increase from the -93.05 % ROCE in the previous year.

The Dimerix ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
-48.41 AUD
Jan 1, 2019
-68.67 AUD
Jan 1, 2020
-57.92 AUD
Jan 1, 2021
-430.51 AUD
Jan 1, 2022
-72.41 AUD
Jan 1, 2023
-230.51 AUD
Jan 1, 2024
-93.05 AUD
Jan 1, 2025
-231.75 AUD
The Dimerix ROCE history
YEARROCEYoY
-231.75 %+149.05%
-93.05 %-59.63%
-230.51 %+218.33%
-72.41 %-83.18%
-430.51 %+643.27%
-57.92 %-15.66%
-68.67 %+41.87%
-48.41 %-27.61%
-66.87 %+17.20%
-57.06 %+173.44%
-20.87 %-55.23%
-46.61 %
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Dimerix's Return on Capital Employed (ROCE)

Dimerix's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Dimerix's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Dimerix's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Dimerix’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Dimerix stock

Return on Capital Employed (ROCE) of Dimerix is -231.75 % in 2026.

Return on Capital Employed (ROCE) of Dimerix changed from -93.05 % to -231.75 %, representing a 149.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Dimerix since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Dimerix with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

Profitability — Dimerix

All Key Metrics — Dimerix